Co-Target(s) Information
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T47623 | Target Info | |||
Target Name | Heparanase (HPSE) | ||||
Synonyms |
Hpa1; Heparanase-1; Heparanase 8 kDa subunit; Heparanase 50 kDa subunit; HSE1; HPSE1; HPR1; HPA; HEP protein; Endo-glucoronidase
Click to Show/Hide
|
||||
Target Type | Successful Target | ||||
Gene Name | HPSE | ||||
Biochemical Class | Glycosylase | ||||
UniProt ID |
Co-Targets of This Target | Top | |||||
---|---|---|---|---|---|---|
Co-Target Name | Human immunodeficiency virus Reverse transcriptase (HIV RT) | Successful Target | ||||
UniProt ID | POL_HV1B1 | |||||
Gene Name | HIV RT | |||||
Synonyms |
HIV p66 RT; HIV Exoribonuclease H
Click to Show/Hide
|
|||||
Representative Drug(s) | Drug Info | IC50 = 18 ug.mL-1 | [1] | |||
Co-Target Name | NAD-dependent deacetylase sirtuin-1 (SIRT1) | Clinical trial Target | ||||
UniProt ID | SIR1_HUMAN | |||||
Gene Name | SIRT1 | |||||
Synonyms |
hSIRT1; hSIR2; SIR2L1; SIR2-like protein 1; Regulatory protein SIR2 homolog 1; NAD-dependent protein deacetylase sirtuin-1
Click to Show/Hide
|
|||||
Representative Drug(s) | Drug Info | IC50 = 300 nM | [2] | |||
Co-Target Name | P2Y purinoceptor 11 (P2RY11) | Discontinued Target | ||||
UniProt ID | P2Y11_HUMAN | |||||
Gene Name | P2RY11 | |||||
Synonyms |
P2Y11
Click to Show/Hide
|
|||||
Representative Drug(s) | Drug Info | Ki = 112.2 nM | [3] |
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Evaluation of natural products as inhibitors of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase. J Nat Prod. 1991 Jan-Feb;54(1):143-54. | ||||
REF 2 | Inhibitors of the NAD(+)-Dependent Protein Desuccinylase and Demalonylase Sirt5. ACS Med Chem Lett. 2012 Oct 6;3(12):1050-3. | ||||
REF 3 | Synthesis and structure-activity relationships of suramin-derived P2Y11 receptor antagonists with nanomolar potency. J Med Chem. 2005 Nov 3;48(22):7040-8. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.